New Delhi, February 12 Zydus Lifesciences announced on Thursday that it will pay USD 120 million to Astellas Pharma to settle a patent dispute over a medication for treating an overactive bladder.Zydus Pharmaceuticals USA, Inc, a wholly-owned subsidiary of the company, has entered into a...